5
1H NMR (400 MHz, CDCl3) δ 8.07 (d, J =
A
8.
C
2 H
C
z
E
, 2
P
H
T
)
E
, 7
D
.77MA
1
N
-(
U
3-c
S
hl
C
or
R
op
I
henyl)-2-(pyrrolidin-1-yl)ethane-1,2-dione (3n)
P
T
(d, J = 8.2 Hz, 2H), 3.73-3.71 (m, 2H), 3.30 (t, J = 5.5 Hz,
2H), 1.71-1.70 (m, 4H), 1.59-1.55 (m, 2H). 13C NMR (125
MHz, CDCl3) δ 190.5, 164.6, 135.9, 135.8, 135.6, 129.9,
126.1, 126.0, 47.1, 42.4, 26.3, 25.5, 24.4. HRMS (ESI) calcd
for C14H14F3NaNO2 ([M+Na]+): 308.0874, found 308.0869.
1H NMR (400 MHz, CDCl3) δ 7.87 (t, J = 1.7 Hz, 1H), 7.87-
7.85 (m, 1H ), 7.58-7.56 (m, 1H), 7.44-7.40 (m, 1H), 3.62 (t, J
= 6.9 Hz, 2H), 3.42 (t, J = 6.7 Hz, 2H), 1.95-1.91 (m, 4H). 13C
NMR (125 MHz, CDCl3) δ 189.9, 164.0, 135.2, 134.6, 134.5,
130.3, 129.7, 128.1, 46.8, 45.4, 25.9, 23.9. HRMS (ESI)
calcd for C12H12ClNaNO2 ([M+Na]+): 260.0454, found
260.0449.
1-morpholino-2-phenylethane-1,2-dione (3g)
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 7.2 Hz, 2H ), 7.63
(t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 3.77-3.74 (m,
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)ethane-1,2-dione (3o)
1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.6 Hz, 2H ), 7.47
(d, J = 8.6 Hz, 2H), 3.64 (t, J = 6.9 Hz, 2H), 3.43 (t, J = 6.6
Hz, 2H), 1.97-1.92 (m, 4H). 13C NMR (125 MHz, CDCl3) δ
190.1, 164.2, 141.1, 131.8, 131.3, 129.3, 46.8, 45.4, 25.9,
23.9. HRMS (ESI) calcd for C12H12ClNaNO2 ([M+Na]+):
260.0454, found 260.0451.
4H), 3.62 (t, J = 4.8 Hz, 2H), 3.35 (t, J = 4.8 Hz, 2H). 13
C
NMR (125 MHz, CDCl3) 191.1, 165.4, 134.9, 133.0, 129.6,
129.1, 66.7, 66.6, 46.2, 41.6.
1-(3-chlorophenyl)-2-morpholinothane-1,2-dione (3h)
1H NMR (300 MHz, CDCl3) δ 7.94 (t, J = 7.7 Hz, 1H), 7.85-
7.82(m, 1H ), 7.64-7.60 (m, 1H), 7.49-7.44 (m, 1H), 3.80-3.77
(m, 4H), 3.66 (t, J = 4.8 Hz, 2H), 3.38 (t, J = 4.8 Hz, 2H). 13C
NMR (75 MHz, CDCl3) δ 189.6, 164.7, 135.5, 134.8, 134.7,
130.4, 129.4, 127.9, 66.7, 66.6, 46.3, 41.8. HRMS (ESI) calcd
for C12H12ClNaNO3 ([M+Na]+):276.0403, found 276.0401.
1-(4-bromophenyl)-2-(pyrrolidin-1-yl)ethane-1,2-dione (3p)
1H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 8.6 Hz, 2H), 7.64
(d, J = 8.6 Hz, 2H), 3.64 (t, J = 7.0 Hz, 2H), 3.43 (t, J = 6.7
Hz, 2H), 1.97-1.92 (m, 4H). 13C NMR (125 MHz, CDCl3) δ
190.3, 164.2, 132.3, 131.9, 131.4, 130.1, 46.8, 45.4, 25.9,
23.9. HRMS (ESI) calcd for C12H12BrNaNO2 ([M+Na]+):
303.9949, found 303.9945.
1-(4-chlorophenyl)-2-morpholinothane-1,2-dione (3i)
1H NMR (300 MHz, CDCl3) δ 7.90 (d, J =8.6 Hz, 2H), 7.49
(d, J =8.6 Hz, 2H), 3.80-3.77 (m, 4H), 3.66 (t, J = 4.8 Hz,
2H), 3.38 (t, J = 4.8 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ
189.7, 164.9, 141.6, 131.5, 131.0, 129.5, 66.7, 66.6, 46.3,
41.7.
1-(pyrrolidin-1-yl)-2[4-(trifluoromethyl)phenyl]ethane-1,2-
dione (3q)
1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8.1 Hz, 2H), 7.76
(d, J = 8.2 Hz, 2H), 3.67 (t, J = 7.0 Hz, 2H), 3.46 (t, J = 6.7
Hz, 2H), 1.98-1.93 (m, , 4H). 13C NMR (125 MHz, CDCl3) δ
189.9, 163.8, 135.8, 130.3, 125.9, 125.8, 124.5, 46.8, 45.5,
25.9, 23.9.
1-(2-chlorophenyl)-2-morpholinoethane-1,2-dione (3j)
1H NMR (300 MHz, CDCl3) δ 7.88 (dd, J =7.8, 1.6 Hz, 1H),
7.55-7.50 (m, 1H), 7.46-7.40 (m, 2H), 3.82-3.79 (m, 2H),
3.78-3.73 (m, 4H), 3.56 (t, J = 4.8 Hz, 2H). 13C NMR (75
MHz, CDCl3) δ 189.7, 165.5, 134.5, 133.6, 133.5, 132.3,
130.8, 127.4, 66.3, 66.2, 46.2, 41.9. HRMS (ESI) calcd for
C12H12ClNaNO3 ([M+Na]+): 276.0403, found 276.0403.
1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)ethane-1,2-dione (3r)
1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 9.0 Hz, 2H), 6.95
(d, J = 9.0 Hz, 2H), 3.88 (s, 3H), 3.63 (t, J = 6.7 Hz, 2H), 3.41
(t, J = 6.5 Hz, 2H), 1.96-1.92 (m, 4H). 13C NMR (125 MHz,
CDCl3) δ 190.3, 165.3, 164.8, 132.4, 126.0, 114.3, 55.6, 46.7,
45.2, 25.9, 24.1.
1-morpholino-2-(4-nitrophenyl)ethane-1,2-dione (3k)
1H NMR (400 MHz, CDCl3) δ 8.37 (d, J =8.9 Hz, 2H), 8.18
(d, J =8.9 Hz, 2H), 3.83-3.80 (m, 4H), 3.71 (t, J = 4.8 Hz,
2H), 3.44 (t, J = 4.8 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ
188.7, 164.0, 151.2, 137.5, 130.9, 124.2, 66.8, 66.7, 46.4,
42.0.
N,N-diethyl-2-oxo-2-phenylacetamide (3s)
1H NMR (300 MHz, CDCl3) δ 7.94 (d, J = 7.0 Hz, 2H),7.63
(t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.5 Hz, 2H), 3.57 (q, J = 7.2
Hz, 2H), 3.25 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H),
1.16 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 191.6,
166.7, 134.5, 133.3, 129.6, 128.9, 42.1, 38.8, 14.1, 12.8.
1-(4-bromophenyl)-2-morpholinothane-1,2-dione (3l)
1H NMR (300 MHz, CDCl3) δ 7.83 (d, J =8.5 Hz, 2H), 7.67
(d, J = 8.5 Hz, 2H), 3.80-3.77 (m, 4H), 3.66 (t, J = 4.8 Hz,
2H), 3.38 (t, J = 4.8 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ
189.5, 164.4, 132.1, 131.5, 130.6, 130.0, 66.3, 66.2, 45.9,
41.3.
2-(3-chlorophenyl)-N,N-diethyl-2-oxoacetamide (3t)
1H NMR (400 MHz, CDCl3) δ 7.93 (s, 1H), 7.81 (d, J = 7.7
Hz, 1H), 7.61-7.59 (m, 1H), 7.47-7.43 (m, 1H), 3.56 (q, J =
7.2 Hz, 2H), 3.24 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H),
1.17 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 190.0,
160.0, 135.4, 134.9, 134.5, 130.3, 129.4, 127.9, 42.2, 39.0,
14.2, 12.8.
1-phenyl-2-(pyrrolidin-1-yl)ethane-1,2-dione (3m)
1H NMR (300 MHz, CDCl3) δ 7.99 (d, J = 7.1 Hz, 2H), 7.66-
7.61 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.5 Hz, 2H), 3.66 (t, J =
7.0 Hz, 2H), 3.42 (t, J = 6.8 Hz, 2H), 1.97-1.92 (m, 4H). 13C
NMR (75 MHz, CDCl3) δ 191.6, 164.9, 134.6, 132.9, 129.9,
128.9, 46.7, 45.2, 25.9, 24.0.
2-(4-bromophenyl)-N,N-diethyl-2-oxoacetamide (3u)
1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.5 Hz, 2H), 7.65
(d, J = 8.5 Hz, 2H), 3.55 (q, J = 7.2 Hz, 2H), 3.23 (q, J = 7.1